Pregled bibliografske jedinice broj: 436308
Vascular endothelial growth factor in children with neuroblastoma:a retrospective analysis
Vascular endothelial growth factor in children with neuroblastoma:a retrospective analysis // Journal of Experimental & Clinical Cancer Research, 28 (2009), 143-1 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 436308 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Vascular endothelial growth factor in children with neuroblastoma:a retrospective analysis
Autori
Jakovljević, Gordana ; Čulić, Srđana ; Stepan, Jasminka ; Bonevski, Aleksandra ; Seiwerth, Sven
Izvornik
Journal of Experimental & Clinical Cancer Research (1756-9966) 28
(2009);
143-1
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
VEGF; neuroblastoma
Sažetak
Despite aggressive therapy, advanced stage neuroblastoma patients have poor survival rates. Although angiogenesis correlates with advanced tumour stage and plays an important role in determining the tumour response to treatment in general, clinical data are still insufficient, and more clinical evaluations are needed to draw conclusions. The aim of this study was to evaluate vascular endothelial growth factor (VEGF) expression in patients with neuroblastoma, determine whether it correlates with other prognostic factors and/or therapeutic response, and to assess should VEGF be considered in a routine diagnostic workup. VEGF expression was determined by immunohistochemistry using anti-VEGF antibody in paraffin embedded primary tumour tissue from 56 neuroblastoma patients. Semiquantitative expression of VEGF was estimated and compared with gender, age, histology, disease stage, therapy, and survival. Statistical analyses, including multivariate analysis, were performed. VEGF expression correlated with disease stage and survival in neuroblastoma patients. Combination of VEGF expression and disease stage as a single prognostic value for survival (P-value = 0.0034 ; odds ratio (OR) (95%CI) = 26.17 (2.97-230.27) exhibited greater correlation with survival than individually. Hematopoietic stem cell transplantation significantly improved survival of the advanced stage patients with high VEGF expression. VEGF expression should be considered in a routine diagnostic workup of children with neuroblastoma, especially in those more than 18 months old and with advanced disease stage. High VEGF expression at the time of disease diagnosis is a bad risk prognostic factor, and can be used to characterize subsets of patients with an unfavourable outcome.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
053-0532264-2260 - Komparativna dijagnostika, morfometrija i analiza tumora ljudi i životinja (Grabarević, Željko, MZOS ) ( CroRIS)
098-0982464-3120 - Farmakogenetika u dječjoj onkologiji (Stepan Giljević, Jasminka, MZOS ) ( CroRIS)
108-1083570-3643 - Kvantitativna analiza i prijenos slike u patologiji (Seiwerth, Sven, MZOS ) ( CroRIS)
Ustanove:
Klinika za dječje bolesti Medicinskog fakulteta,
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb,
Medicinski fakultet, Split,
Sveučilište u Splitu,
Sveučilište u Zagrebu
Profili:
Gordana Jakovljević
(autor)
Sven Seiwerth
(autor)
Aleksandra Bonevski
(autor)
Srđana Čulić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE